Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss.

Abstract

Adenosine A1 receptors (A1AR) are well characterized for their role in cytoprotection. Previous studies have demonstrated the presence of these receptors in the cochlea where their activation were shown to suppress cisplatin-induced inflammatory response and the resulting ototoxicity. Inhibition of A1AR by caffeine, a widely consumed psychoactive substance, could antagonize the endogenous protective role of these receptors in cochlea and potentiate cisplatin-induced hearing loss. This hypothesis was tested in a rat model of cisplatin ototoxicity following oral administration of caffeine. We report here that single-dose administration of caffeine exacerbates cisplatin-induced hearing loss without increasing the damage to outer hair cells (OHCs), but increased synaptopathy and inflammation in the cochlea. These effects of caffeine were mediated by its blockade of A1AR, as co-administration of R-PIA, an A1AR agonist, reversed the detrimental actions of caffeine and cisplatin on hearing loss. Multiple doses of caffeine exacerbated cisplatin ototoxicity which was associated with damage to OHCs and cochlear synaptopathy. These findings highlight a possible drug-drug interaction between caffeine and cisplatin for ototoxicity and suggest that caffeine consumption should be cautioned in cancer patients treated with a chemotherapeutic regimen containing cisplatin.

• Authors: Sandeep Sheth, Kelly Sheehan, Asmita Dhukhwa, Raheem F H Al Aameri, Chaitanya Mamillapalli, Debashree Mukherjea, Leonard P Rybak, Vickram Ramkumar
• Journal: Scientific reports (Sci Rep) Vol. 9 Issue 1 Pg. 9571 (07 02 2019) ISSN: 2045-2322 [Electronic] England
• PMID: 31267026 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• Biomarkers
• Central Nervous System Stimulants
• Caffeine
• Cisplatin

Topics

• Administration, Oral
• Animals
• Antineoplastic Agents (adverse effects)
• Apoptosis (drug effects)
• Biomarkers
• Caffeine (administration & dosage, adverse effects)
• Central Nervous System Stimulants (administration & dosage, adverse effects)
• Cisplatin (adverse effects)
• Cochlea (drug effects)
• Drug Synergism
• Fluorescent Antibody Technique
• Hearing Loss (etiology, metabolism, pathology)
• Inflammation (etiology, metabolism, pathology)
• Rats
• Synaptic Potentials (drug effects)